NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/18/2024
Back to search
Official data from USPTO
DOTENDO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
DOTENDO
ST13
US500000088567308Class
5, 42, 44
Filing
88567308
Registration
7422292
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
59
Latest update
06/18/2024
Trademark type
Word
Nice classes
5, 42, 44
Filing date
08/05/2019
Registration date
06/18/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/18/2024
Last transaction
06/18/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/15/2022
First use in commerce
08/15/2022
Drawing code
4
Owner type
03
Owner location
Branford, CT, US
Examiner
PULVERMACHER, TASHA NICOLE
Law office
M10
Current location
TMO LAW OFFICE 110
Holders and representatives
Holders
DOT LABORATORIES, INC.
Representatives
Ryan S. Hilbert HOLLEY & MENKER, PA
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medical diagnostic tests comprised of assays that test for the presence of medical biomarkers present in human body fluids by applying advanced analytics; Medical diagnostic tests comprised of assays that test for the presence of medical biomarkers present in human body fluids by applying machine learning technology for use in detecting endometriosis
Class 42
Providing medical testing services and information in the field of endometriosis for medical research purposes; Providing scientific analysis and informational reports based upon results of laboratory testing in the field of endometriosis; Scientific research in the field of endometriosis; Computer serviceshosting and maintaining an online portal for others to access and share informationtest results and data in the field of endometriosis; Scientific research in the field of endometriosis
Class 44
Medical diagnostic testingmonitoring and reporting services; Medical testing for diagnostic or treatment purposes; Consulting services in the fields of diagnostic medical testing; Providing medical informationconsultancy and advisory services; Providing medical testing services and information in the field of endometriosis for diagnostic or treatment purposes; Medical testing servicesdiagnostic testing services for detecting endometriosis by identifying and analyzing biomarkers for diagnostic or treatment purposes
Publications
History of USPTO decisions and trademark events.
59 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/18/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/15/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/15/2024
DOCK
ASSIGNED TO EXAMINER
04/24/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/22/2024
IUAF
USE AMENDMENT FILED
03/19/2024
EISU
TEAS STATEMENT OF USE RECEIVED
03/19/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/05/2023
EX5G
SOU EXTENSION 5 GRANTED
10/04/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/02/2023
EXT5
SOU EXTENSION 5 FILED
09/22/2023
EEXT
SOU TEAS EXTENSION RECEIVED
09/22/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/25/2023
EX4G
SOU EXTENSION 4 GRANTED
03/23/2023
EXT4
SOU EXTENSION 4 FILED
03/23/2023
EEXT
SOU TEAS EXTENSION RECEIVED
03/23/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/21/2022
EX3G
SOU EXTENSION 3 GRANTED
09/19/2022
EXT3
SOU EXTENSION 3 FILED
09/19/2022
EEXT
SOU TEAS EXTENSION RECEIVED
09/19/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/22/2022
EX2G
SOU EXTENSION 2 GRANTED
03/19/2022
EXT2
SOU EXTENSION 2 FILED
03/19/2022
EEXT
SOU TEAS EXTENSION RECEIVED
03/19/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/11/2021
EX1G
SOU EXTENSION 1 GRANTED
09/09/2021
EXT1
SOU EXTENSION 1 FILED
09/09/2021
EEXT
SOU TEAS EXTENSION RECEIVED
09/09/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/23/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/26/2021
PUBO
PUBLISHED FOR OPPOSITION
01/26/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/12/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/12/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/12/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/06/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/21/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
12/14/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/14/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
12/14/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/14/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/12/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/11/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/11/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/29/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/29/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/29/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/11/2020
GNFR
FINAL REFUSAL E-MAILED
06/11/2020
CNFR
FINAL REFUSAL WRITTEN
06/11/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/18/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/18/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/18/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/19/2019
GNRT
NON-FINAL ACTION E-MAILED
11/19/2019
CNRT
NON-FINAL ACTION WRITTEN
11/19/2019
DOCK
ASSIGNED TO EXAMINER
11/04/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/22/2019
NWAP
NEW APPLICATION ENTERED
08/08/2019
Continuous trademark protection
Get notified about every new filing that threatens DOTENDO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.